Portfolio

WAYNE, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has ...

(2021 July). Journal of the American College of Surgeons, 219(3), 430–438. Surgical Endoscopy, 35(7), 4016–4021. (2014 Sept.). Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. Teleflex, the Teleflex logo, Arrow, Deknatel, LMA, Pilling, QuikClot, Rüsch, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. The transaction is expected to be accretive to revenue growth and adjusted EPS thereafter. “The acquisition of Standard Bariatrics adds an exciting and differentiated product serving the large and growing sleeve gastrectomy market, which we estimate to be approximately 120,000 procedures5 annually in the U.S. We also expect that the acquisition will exceed our cost of capital by the end of the fourth year following the completion of the acquisition.” While every patient's anatomy is different, the Titan SGS® long staple line enables surgeons to plan and place staples in one firing, minimizing variations sometimes associated with the use of multiple overlapping short-cartridge staple firings1,3. Under the terms of the agreement, Teleflex will acquire Standard Bariatrics for an upfront cash payment of $170 million at closing, with additional consideration of up to $130 million payable upon the achievement of certain commercial milestones. The acquisition is subject to customary closing conditions, including receipt of certain regulatory approvals, and is expected to be completed early in the fourth quarter of 2022.